Core Insights - Oracle (ORCL) shares are presented as a more attractive investment option compared to Synopsys (SNPS) due to better revenue growth, enhanced profitability, and lower valuation metrics [2]. Financial Performance Comparison - ORCL's revenue growth over the last 12 months was 9.7%, while SNPS reported 8.0% [2]. - Over the past three years, ORCL's average revenue growth was 10.2%, exceeding SNPS's 9.7% [2]. - ORCL's last twelve months (LTM) profit margin was 31.6%, compared to SNPS's performance [2]. - The three-year average profit margin for ORCL was 30.3%, again outperforming SNPS [2]. Valuation Metrics - A side-by-side analysis of financials indicates that ORCL has superior growth, margins, momentum, and valuation multiples compared to SNPS [3].
Bet On Oracle Or Synopsys?